EC Clinical and Medical Case Reports

Editorial Volume 7 Issue 2 - 2024

Synthetic Genomics to ‘Unmasking the Masquerades’ as Potential Vaccine Biomarkers in Multi-Drug-Resistance Mycobacterium tuberculosis (MDR-TB)

Irokanulo Emenike Onyebum1, Adeoti Olatunde Micheal1,2* and Ndako James1

1Department of Microbiology, Landmark University, Omu-Aran Kwara State, Nigeria

2Department of Microbiology, P.M.B 021, The Oke-Ogun Polytechnic, Saki, Nigeria

*Corresponding Author: Adeoti Olatunde Micheal, Department of Microbiology, P.M.B 021, The Oke-Ogun Polytechnic, Saki, Nigeria.
Received: January 25, 2024; Published: January 30, 2023




Death tolls due to Mycobacterium tuberculosis infections remained increasingly high despite an intensive global fight against TB. Biomarkers are measurable indicators that can be used to diagnose or monitor disease progression which are usually host and pathogen-derived.

Adeoti Olatunde Micheal., et al. "Synthetic Genomics to ‘Unmasking the Masquerades’ as Potential Vaccine Biomarkers in Multi-Drug-Resistance Mycobacterium tuberculosis (MDR-TB)." EC Clinical and Medical Case Reports   7.2 (2024): 01-02.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net